相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Virtual Ligand Screening of the p300/CBP Histone Acetyltransferase: Identification of a Selective Small Molecule Inhibitor
Erin M. Bowers et al.
CHEMISTRY & BIOLOGY (2010)
A novel exon in AML1-ETO negatively influences the clonogenic potential of the t(8;21) in acute myeloid leukemia
D. Mannari et al.
LEUKEMIA (2010)
RUNX1/AML1 DNA-binding domain and ETO/MTG8 NHR2-dimerization domain are critical to AML1-ETO9a leukemogenesis
Ming Yan et al.
BLOOD (2009)
Structure of the AML1-ETO eTAFH domain-HEB peptide complex and its contribution to AML1-ETO activity
Sangho Park et al.
BLOOD (2009)
Post-translational modifications of Runx1 regulate its activity in the cell
Lan Wang et al.
BLOOD CELLS MOLECULES AND DISEASES (2009)
Balancing dormant and self-renewing hematopoietic stem cells
Anne Wilson et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2009)
Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells
Andrea Viale et al.
NATURE (2009)
Transforming activity of AML1-ETO is independent of CBFβ and ETO interaction but requires formation of homo-oligomeric complexes
Colin Kwok et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
Chunaram Choudhary et al.
SCIENCE (2009)
t(8;21)(q22;q22) fusion proteins preferentially bind to duplicated AML1/RUNX1 DNA-binding sequences to differentially regulate gene expression
Akiko J. Okumura et al.
BLOOD (2008)
Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity
Xinyang Zhao et al.
GENES & DEVELOPMENT (2008)
Eriocalyxin B induces apoptosis of t(8;21) leukemia cells through NF-κB and MAPK signaling pathways and triggers degradation of AML1-ETO oncoprotein in a caspase-3-dependent manner
L. Wang et al.
CELL DEATH AND DIFFERENTIATION (2007)
Id1 restrains myeloid commitment, maintaining the self-renewal capacity of hematopoietic stem cells
Vladimir Jankovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis
Ming Yan et al.
NATURE MEDICINE (2006)
The tetramer structure of the Nervy homology two domain, NHR2, is critical for AM1/ETO's activity
YZ Liu et al.
CANCER CELL (2006)
Synthesis and evaluation of a potent and selective cell-permeable p300 histone acetyltransferase inhibitor
YJ Zheng et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
The t(8;21) translocation converts AML1 into a constitutive transcriptional repressor
J Wildonger et al.
DEVELOPMENT (2005)
AML1 is functionally regulated through p300-mediated acetylation on specific lysine residues
Y Yamaguchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
E protein silencing by the leukemogenic AML1-ETO fusion protein
JS Zhang et al.
SCIENCE (2004)
Effects of the leukemia-associated AML1-ETO protein on hematopoietic stem and progenitor cells
SD Nimer et al.
ONCOGENE (2004)
The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia
RK Vangala et al.
BLOOD (2003)
The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells
JC Mulloy et al.
BLOOD (2002)
Histone deacetylases: a common molecular target for differentiation treatment of acute myeloid leukemias?
S Minucci et al.
ONCOGENE (2001)
AML1-ETO downregulates the granulocytic differentiation factor C/EBPα in t(8;21) myeloid leukemia
T Pabst et al.
NATURE MEDICINE (2001)
分享论文
